“When you reach out and touch these molecular strings, you are touching the absolute real physics,” Glowacki told the Times. “The way that it moves and behaves is to the best of our knowledge the real deal.”

In addition to making it more efficient to solve 3D problems at the molecular level, the VR tool could allow researchers at pharmaceutical companies and universities in different locations to look at molecules at the same time.

Read The New York Times' entire article below: